MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 99 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,984,555 | +6.7% | 27,284 | +68.7% | 0.00% | +50.0% |
| Q2 2023 | $3,735,963 | -35.5% | 16,173 | -32.4% | 0.00% | -50.0% |
| Q1 2023 | $5,793,163 | -60.1% | 23,913 | -52.2% | 0.00% | -66.7% |
| Q4 2022 | $14,526,722 | +271.1% | 50,049 | -16.9% | 0.01% | +300.0% |
| Q3 2022 | $3,915,000 | -19.7% | 60,247 | -11.6% | 0.00% | -25.0% |
| Q2 2022 | $4,875,000 | +517.1% | 68,116 | +746.4% | 0.00% | – |
| Q1 2022 | $790,000 | -69.6% | 8,048 | -73.8% | 0.00% | -100.0% |
| Q4 2021 | $2,602,000 | -13.7% | 30,700 | -18.8% | 0.00% | -50.0% |
| Q3 2021 | $3,016,000 | -84.4% | 37,793 | -81.0% | 0.00% | -83.3% |
| Q2 2021 | $19,346,000 | +368.7% | 198,601 | +462.7% | 0.01% | +300.0% |
| Q1 2021 | $4,128,000 | +1512.5% | 35,293 | +1431.1% | 0.00% | – |
| Q4 2020 | $256,000 | +194.3% | 2,305 | +214.9% | 0.00% | – |
| Q3 2020 | $87,000 | -92.3% | 732 | -92.7% | 0.00% | -100.0% |
| Q2 2020 | $1,136,000 | +82.1% | 10,024 | +7.3% | 0.00% | 0.0% |
| Q1 2020 | $624,000 | +89.1% | 9,341 | +158.0% | 0.00% | – |
| Q4 2019 | $330,000 | -83.8% | 3,620 | -84.6% | 0.00% | -100.0% |
| Q3 2019 | $2,031,000 | -55.3% | 23,558 | -45.7% | 0.00% | -50.0% |
| Q2 2019 | $4,546,000 | +3424.0% | 43,365 | +4134.9% | 0.00% | – |
| Q1 2019 | $129,000 | -97.7% | 1,024 | -98.0% | 0.00% | -100.0% |
| Q4 2018 | $5,635,000 | +159.4% | 49,993 | +392.9% | 0.01% | +200.0% |
| Q3 2018 | $2,172,000 | -23.8% | 10,142 | -0.5% | 0.00% | -33.3% |
| Q2 2018 | $2,851,000 | +48.5% | 10,195 | -38.0% | 0.00% | +50.0% |
| Q1 2018 | $1,920,000 | +1180.0% | 16,438 | +904.8% | 0.00% | – |
| Q4 2017 | $150,000 | -18.9% | 1,636 | -85.6% | 0.00% | – |
| Q2 2017 | $185,000 | – | 11,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |